WEDNESDAY, April 26, 2023 (HealthDay News) – The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The medication, toferson (Qalsody), targets a mutation in the SOD1-ALS gene. ALSContinue Reading

THURSDAY, Dec. 15, 2022 (HealthDay News) — Quitting alcohol can help reduce complications of liver cirrhosis, even in patients who have advanced disease. It can also help them live longer, new research shows. “Our results clearly show that all patients with alcohol-related liver cirrhosis who maintain sustained abstinence from alcoholContinue Reading

WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Bees, in their role as master pollinators, increase crop yields, leading to more production of healthy fruits, vegetables and nuts. But new research claims that the challenges these important insects face from changes in land use, harmful pesticides and climate change is affectingContinue Reading

MONDAY, Sept. 26, 2022 (HealthDay News) — People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS), a new study found. “This study shows that certain occupational settings and exposures increase one’s chances ofContinue Reading